Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rodriguez-Torres, M.
~ 31000  Ergebnisse:
Personensuche X
?
1

Geobacter sulfurreducens electroactive biofilms on Fe2O3/FT..:

Huerta-Miranda, G.A. ; Rodríguez-Torres, L.M. ; Martínez-García, A.L....
Biosensors and Bioelectronics: X.  14 (2023)  - p. 100370 , 2023
Link: https://doi.org/10.1016/..
 
?
2

High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12..:

Lawitz, E. ; Kowdley, K. ; Curry, M....
Journal of Hepatology.  64 (2016)  2 - p. S139-S140 , 2016
Link: https://doi.org/10.1016/..
 
?
3

SOF/VEL for 12 Weeks Is Well Tolerated and Results in High ..:

Grebely, J. ; Dore, G.J. ; Aspinall, R....
Journal of Hepatology.  64 (2016)  2 - p. S776 , 2016
Link: https://doi.org/10.1016/..
 
?
4

P0898 : TD-6450, A next generation once-daily NS5A inhibito..:

Lawitz, E. ; Rodriguez-Torres, M. ; Kohler, R....
Journal of Hepatology.  62 (2015)  - p. S680-S681 , 2015
Link: https://doi.org/10.1016/..
 
?
5

P0901 : The pan-genotypic NS3/4A protease inhibitor GS-9857..:

Rodriguez-Torres, M. ; Glass, S. ; Hill, J....
Journal of Hepatology.  62 (2015)  - p. S682 , 2015
Link: https://doi.org/10.1016/..
 
?
6

P1173 THE IMPACT OF HIV CO-INFECTION ON RATES AND SEVERITY ..:

Naggie, S. ; Sulkowski, M. ; Gaggar, A....
Journal of Hepatology.  60 (2014)  1 - p. S475-S476 , 2014
Link: https://doi.org/10.1016/..
 
?
7

O7 ONCE-DAILY SIMEPREVIR (TMC435) PLUS SOFOSBUVIR (GS-7977)..:

Sulkowski, M. ; Jacobson, I.M. ; Ghalib, R....
Journal of Hepatology.  60 (2014)  1 - p. S4 , 2014
Link: https://doi.org/10.1016/..
 
?
8

P1126 IMPACT OF SAFETY-RELATED DOSE REDUCTIONS AND DISCONTI..:

Foster, G.R. ; Coppola, C. ; Curescu, M....
Journal of Hepatology.  60 (2014)  1 - p. S455 , 2014
Link: https://doi.org/10.1016/..
 
?
9

O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN H..:

Lawitz, E. ; Ghalib, R. ; Rodriguez-Torres, M....
Journal of Hepatology.  60 (2014)  1 - p. S524 , 2014
Link: https://doi.org/10.1016/..
 
?
10

P1222 A PHASE II STUDY OF SAMATASVIR (IDX719) IN COMBINATIO..:

Lawitz, E. ; Rodriguez-Torres, M. ; Nguyen, T....
Journal of Hepatology.  60 (2014)  1 - p. S495-S496 , 2014
Link: https://doi.org/10.1016/..
 
?
11

COL01-03: PHOTON-1 : association sofosbuvir-ribavirine pour..:

Molina, J.-M. ; Naggie, S. ; Sulkowski, M....
Médecine et Maladies Infectieuses.  44 (2014)  6 - p. 1-2 , 2014
Link: https://doi.org/10.1016/..
 
?
12

1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOF..:

Sulkowski, M.S. ; Gardiner, D.F. ; Rodriguez-Torres, M....
Journal of Hepatology.  58 (2013)  - p. S570 , 2013
Link: https://doi.org/10.1016/..
 
?
13

1411 SOFOSBUVIR + PEGINTERFERON + RIBAVIRIN FOR 12 WEEKS AC..:

Lawitz, E. ; Wyles, D. ; Davis, M....
Journal of Hepatology.  58 (2013)  - p. S567 , 2013
Link: https://doi.org/10.1016/..
 
?
14

1423 INTERIM ANALYSIS OF AN INTERFERON (IFN)- AND RIBAVIRIN..:

Everson, G.T. ; Sims, K.D. ; Rodriguez-Torres, M....
Journal of Hepatology.  58 (2013)  - p. S573 , 2013
Link: https://doi.org/10.1016/..
 
?
15

1206 PHARMACODYNAMICS OF ORAL TLR-7 AGONIST GS-9620 IN TREA..:

Lawitz, E. ; Gruener, D. ; Marbury, T....
Journal of Hepatology.  58 (2013)  - p. S490 , 2013
Link: https://doi.org/10.1016/..
 
1-15